Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR2 | P41597 | 9/20 | 0.47 |
| ▸ | GPR139 | Q6DWJ6 | 5/20 | 0.40 |
| ▸ | PSMB11 | A5LHX3 | 3/20 | 0.39 |
| ▸ | PSMA7 | O14818 | 3/20 | 0.39 |
| ▸ | PSMB1 | P20618 | 3/20 | 0.39 |
| ▸ | PSMA1 | P25786 | 3/20 | 0.39 |
| ▸ | PSMA2 | P25787 | 3/20 | 0.39 |
| ▸ | PSMA3 | P25788 | 3/20 | 0.39 |
| ▸ | PSMA4 | P25789 | 3/20 | 0.39 |
| ▸ | PSMB8 | P28062 | 3/20 | 0.39 |
| ▸ | PSMB9 | P28065 | 3/20 | 0.39 |
| ▸ | PSMA5 | P28066 | 3/20 | 0.39 |
| ▸ | PSMB4 | P28070 | 3/20 | 0.39 |
| ▸ | PSMB6 | P28072 | 3/20 | 0.39 |
| ▸ | PSMB5 | P28074 | 3/20 | 0.39 |
| ▸ | PSMB10 | P40306 | 3/20 | 0.39 |
| ▸ | PSMB3 | P49720 | 3/20 | 0.39 |
| ▸ | PSMB2 | P49721 | 3/20 | 0.39 |
| ▸ | PSMA6 | P60900 | 3/20 | 0.39 |
| ▸ | PSMA8 | Q8TAA3 | 3/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3131265 | 0.85 | ALOX5 (0.41) | CCR2GPR139PSMB11PSMA7PSMB1 | |
| SCHEMBL6890206 | 0.84 | ALDH1A1 (0.40) | CCR2GPR139PSMB11PSMA7PSMB1 | |
| SCHEMBL6888038 | 0.84 | ALOX5 (0.51) | CCR2ALOX5 | |
| SCHEMBL3131393 | 0.84 | PSMB11 (0.54) | CCR2GPR139PSMB11PSMA7PSMB1 | |
| SCHEMBL3133296 | 0.81 | CCR2 (0.47) | CCR2 | |
| SCHEMBL17556530 | 0.79 | CCR2 (0.44) | CCR2 | |
| SCHEMBL13753892 | 0.78 | NOS2 (0.43) | CCR2 | |
| SCHEMBL3136843 | 0.77 | SMN1; SMN2 (0.43) | CCR2GPR139PSMB11PSMA7PSMB1 | |
| SCHEMBL3135291 | 0.77 | ESRRB (0.49) | GPR139PSMB11PSMA7PSMB1PSMA1 | |
| SCHEMBL3130090 | 0.76 | PSMB11 (0.40) | CCR2GPR139PSMB11PSMA7PSMB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7807686-B2 | 2-(4-oxo-4H-quinazolin-3-yl)acetamides and their use as vasopressin V3 antagonists | N.V. ORGANON (NL) | 2010-10-05 | — | — | US | disclosed |
| EP-1861380-B1 | 2-(4-OXO-4H-QUINAZOLIN-3-YL)ACETAMIDES AND THEIR USE AS VASOPRESSIN V3 ANTAGONISTS | ORGANON NV (NL) | 2010-07-07 | — | — | EP | disclosed |
| US-20080214553-A1 | 2-(4-Oxo-4H-Quinazolin-3-Yl) Acetamides and Their Use as Vasopressin V3 Antagonists | MERCK SHARP & DOHME B.V. (NL) | 2008-09-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080214553-A1 | 2-(4-Oxo-4H-Quinazolin-3-Yl) Acetamides and Their Use as Vasopressin V3 Antagonists | AVPR2, AVPR1A, AVPR1B | CCR2 1973/4885GPR139 391/4885PSMB11 3118/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.